Citation: Bs. Lindsay et al., ISOLATION OF 2-(3'-BROMO-4'-HYDROXYPHENOL)ETHANAMINE FROM THE NEW-ZEALAND ASCIDIAN CNEMIDOCARPA-BICORNUTA, Journal of natural products, 61(6), 1998, pp. 857-858
Citation: Br. Copp et al., STYELSAMINES A-D - NEW TETRACYCLIC PYRIDOACRIDINE ALKALOIDS FROM THE INDONESIAN ASCIDIAN EUSYNSTYELA-LATERICIUS, Journal of organic chemistry, 63(22), 1998, pp. 8024-8026
Authors:
DEGUZMAN FS
COPP BR
MAYNE CL
CONCEPCION GP
MANGALINDAN GC
BARROWS LR
IRELAND CM
Citation: Fs. Deguzman et al., BOLINAQUINONE - A NOVEL CYTOTOXIC SESQUITERPENE HYDROXYQUINONE FROM APHILIPPINE DYSIDEA SPONGE, Journal of organic chemistry, 63(22), 1998, pp. 8042-8044
Authors:
COPP BR
FAIRCHILD CR
CORNELL L
CASAZZA AM
ROBINSON S
IRELAND CM
Citation: Br. Copp et al., NAAMIDINE-A IS AN ANTAGONIST OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND AN IN-VIVO ACTIVE ANTITUMOR AGENT, Journal of medicinal chemistry, 41(20), 1998, pp. 3909-3911
Citation: Bs. Lindsay et al., EFFICIENT AND CONVENIENT PYRIDINE RING-E FORMATION OF THE CYTOTOXIC MARINE ALKALOID ASCIDIDEMIN AND RELATED ANALOGS, Synthetic communications, 27(15), 1997, pp. 2587-2592
Citation: Bs. Lindsay et al., STRUCTURAL REQUIREMENTS FOR BIOLOGICAL-ACTIVITY OF THE MARINE ALKALOID ASCIDIDEMIN, Bioorganic & medicinal chemistry letters, 5(7), 1995, pp. 739-742
Authors:
AINSWORTH AM
CHICARELLIROBINSON MI
COPP BR
FAUTH U
HYLANDS PJ
HOLLOWAY JA
LATIF M
OBEIRNE GB
PORTER N
RENNO DV
RICHARDS M
ROBINSON N
Citation: Am. Ainsworth et al., XENOVULENE-A, A NOVEL GABA-BENZODIAZEPINE RECEPTOR-BINDING COMPOUND PRODUCED BY ACREMONIUM-STRICTUM, Journal of antibiotics, 48(7), 1995, pp. 568-573
Authors:
COPP BR
FULTON KF
PERRY NB
BLUNT JW
MUNRO MHG
Citation: Br. Copp et al., NATURAL AND SYNTHETIC DERIVATIVES OF DISCORHABDIN-C, A CYTOTOXIC PIGMENT FROM THE NEW-ZEALAND SPONGE LATRUNCULIA CF BOCAGEI, Journal of organic chemistry, 59(26), 1994, pp. 8233-8238
Authors:
BARROWS LR
RADISKY DC
COPP BR
SWAFFAR DS
KRAMER RA
WARTERS RL
IRELAND CM
Citation: Lr. Barrows et al., MAKALUVAMINES, MARINE NATURAL-PRODUCTS, ARE ACTIVE ANTICANCER AGENTS AND DNA TOPO-II INHIBITORS, Anti-cancer drug design, 8(5), 1993, pp. 333-347